Coley Pharmaceutical (COLY)
Coley Pharmaceutical Group, Inc. engages in the discovery and development of drug candidates for cancers, infectious diseases, and respiratory disorders. The company’s product candidates include ProMune, a Phase III clinical trial product for the treatment of cancers; AVE7279 and AVE0675, Phase I clinical trial products for the treatment of respiratory diseases; and VaxImmune Vaccine Adjuvant, a Phase I clinical trial product to treat breast, prostate, lung cancers, and infectious diseases. Coley Pharmaceutical was founded in 1997 and is headquartered in Wellesley, Massachusetts.
read more
QUOTE
As of 04:03AM EDT May 26, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
COLEY PHARMACEUTICAL (COLY) MESSAGE BOARD
